M&A Deal Summary

UAS Laboratories Acquires Nebraska Cultures

On April 14, 2018, UAS Laboratories acquired life science company Nebraska Cultures

Acquisition Highlights
  • This is UAS Laboratories’ 1st transaction in the Life Science sector.
  • This is UAS Laboratories’ 2nd transaction in the United States.
  • This is UAS Laboratories’ 1st transaction in California.

M&A Deal Summary

Date 2018-04-14
Target Nebraska Cultures
Sector Life Science
Buyer(s) UAS Laboratories
Deal Type Add-on Acquisition

Target

Nebraska Cultures

Walnut Creek, California, United States
Nebraska Cultures specializes in custom-manufactured probiotic solutions including the DDS-1 strain of Lactobacillus acidophilus and the ProDURA brand of spore-based probiotics.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

UAS Laboratories

Wausau, Wisconsin, United States

Category Company
Founded 1979
Sector Medical Products
Employees230
DESCRIPTION

UAS Laboratories is a research, development company that manufactures probiotic nutritional supplements. UAS Laboratories was founded in 1979 and is based in Wausau, Wisconsin.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-02 Micropharma - Intellectual Property Assets

United States

Micropharma - Intellectual Property Assets consists of Micropharma and Cardioviva brands

Buy -